Emerging Nephrotic Problems among Diabetic Patients of Bangladesh

Emerging Nephrotic Problems among Diabetic Patients of Bangladesh


Faculty of Pharmacy, World University of Bangladesh

International Research Journal of Diabetes and Metabolism

Nearly 80% of people with diabetes live in low- and middle-income countries. It increases healthcare expenditure and imposes a huge economic burden on the healthcare systems. The International Diabetes Federation estimated more than 7 million people with diabetes in Bangladesh and almost an equal number with unexplored diabetes. This number is estimated to double by 2025. It is a costly condition and may cause stroke, heart attack, chronic kidney diseases, neuropathy, visual impairment and amputations. Bangladesh is a developing country where 75% of total population lives in rural area. Subsequently they have poor healthcare access as 26% of rural professionals remain vacant and nearly 40%, absent. Nearly 45% rural people take medical assessment from unqualified health workers including medical assistants, mid-wives, village doctors, community health workers in comparison to that by qualified medical graduates (only 10%-20%). More than 75% women having complications taken treatment from an unqualified provider. These are mostly because concern over medical costs, and pronounced socioeconomic disparities found for care-seeking behavior in both urban and rural Bangladesh.

Keywords:  Diabetic Patient; Glycemic Control; kidney Function; Stroke; Blood Sugar; Albuminuria

Free Full-text PDF

How to cite this article:
AK MOHIUDDIN.Emerging Nephrotic Problems among Diabetic Patients of Bangladesh. International Research Journal of Diabetes and Metabolism, 2019, 2:6


1. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003 Jul 15; 139(2):137-47.
2. Viberti GC, Mogensen CE, Passa P, et al. St Vincent declaration: guidelines for the prevention of diabetic renal failure. In: Mogensen CE, editor. The kidney and hypertension in diabetes mellitus. Dordrecht: Kluwer Academic Publishers; 1994. pp. 515–527.
3. Roberto PF, Hugo A and others. Interactions between kidney disease and diabetes: dangerous liaisons Diabetol Metab Syndr. 2016; 8: 50. Published online 2016 Jul 28. doi: 10.1186/s13098-016-0159-z PMID: 27471550
4. Kim MK. Treatment of diabetic kidney disease: current and future targets Korean J Intern Med. 2017 Jul; 32(4): 622–630. doi: [10.3904/kjim.2016.219] PMID: 28704915
5. Christina MY, Robert N. Diabetic nephropathy as the cause of end-stage kidney disease reported on the medical evidence form CMS2728 at a single center. Clin Kidney J. 2017 Apr; 10(2): 257–262. doi: [10.1093/ckj/sfw112] PMID: 28396744
6. Allen IA. Diabetic Nephropathy and Treatment of Hypertension. Endotext [Internet]. De Groot LJ, Chrousos G, Dungan K, et al., editors. South Dartmouth (MA): MDText.com, Inc.; 2000-.
7. Nathan DM. Long-term complications of diabetes mellitus. New Engl J Med 1993;328:1676-85.
8. Abdulrhman A. Prevalence of diabetic nephropathy among Type 2 diabetic patients in some of the Arab countries. Int J Health Sci (Qassim). 2017 Jan-Mar; 11(1): 1–4. PMID: 28293155
9. Chaity AJ Obesity blamed for alarming rise in childhood diabetes DhakaTribune November 13th, 2017
10. Star Online Report 80 lakh Bangladeshis suffering from diabetes: State minister The Daily Star April 06, 2016
11. Hayes L, White M, Unwin N, et al. Patterns of physical activity and relationship with risk markers for cardiovascular disease and diabetes in Indian, Pakistani, Bangladeshi and European adults in a UK Professiona population. J Public Health Med 2002; 24(3):170-8.
12. Abrar SMA Diabetes management service launched in Bangladesh DhakaTribune, September 25th, 2018
13. Tareq S. Obesity is increasing among the younger generation in Bangladesh The Daily Star September 23, 2018
14. Ahmed ST, Rahim MA and others. Prevalence of primary renal diseases among patients on maintenance haemodialysis: A hospital based study. KYAMC Journal Vol. 2, No.-2, January 2012
15. Ahmed SS, Khan MAH, Laila TR. Treatment and Prevention of Common Complications of Chronic Kidney Disease Journal of Enam Medical College 2014; 4(1): 45–55
16. Position Statement American Diabetic Association. Standards of medical care in diabetes- 2015. Diabetes care. 2015; 38 (suppl.1): 8-93.
17. Sayama H., Muttalib MA, Islam MI, Khanam PA, Akter N, Akber T Prevalence of Nephropathy with Evaluation of HbA1c Level and other Associated Risk Factors in Type 2 Diabetic Patients in a Tertiary Level Hospital KYAMC Journal Vol. 8, No.-1, Jul 2017, Page 21-26
18. Laily AA, Promita D and others Superoxide dismutase 1 gene +35A>C (intron3/exon3) polymorphism in diabetic nephropathy patients among Bangladeshi population. J Mol Pathophysiol. 2014; 3(4): 52-57 DOI:10.5455/jmp.20141224035706
19. Zabeen B., Nahar J. and others Risk Factors Associated with Microalbuminuria in Children and Adolescents with Diabetes in Bangladesh Indian Journal of Endocrinology and Metabolism Volume 22 Issue 1 January-February 2018
20. Georgi A., Santosh V and others Chronic kidney disease hotspots in developing countries in South Asia Clin Kidney J. 2016 Feb; 9(1): 135–141.doi: [10.1093/ckj/sfv109] PMID: 26798474
21. Mumu SJ, Saleh F and others Non-Adherence to Lifestyle Modification and its Determinants among Bangladeshi type 2 Diabetic Patients International Journal of Epidemiology, Volume 44, Issue suppl_1, 1 October 2015, Pages i148–i149, https://doi.org/10.1093/ije/dyv096.177
22. Shamima A., M Mizanur R. and others of diabetes and prediabetes and their risk factors among Bangladeshi adults: a nationwide survey Bulletin of the World Health Organization Bulletin of the World Health Organization 2014;92:204-213A. doi: http://dx.doi.org/10.2471/BLT.13.128371
23. Lambert P, Bingley PJ. What is Type 1 Diabetes? Medicine 2002;30(1):1‒5
24. Shariful MSI, Andreas L. and others Healthcare use and expenditure for diabetes in Bangladesh BMJ Glob Health. 2017; 2(1): e000033. doi: [10.1136/bmjgh-2016-000033] PMID: 28588991
25. Afsana A., Samira H. and others Healthcare cost of type 2 diabetes mellitus in Bangladesh: a hospital-based study International Journal of Diabetes in Developing Countries June 2016, Volume 36, Issue 2, pp 235–241
26. Sarker AR, Marufa S. Letter To The Editor Health and economic burden of diabetes in Bangladesh: Priorities for attention and control Journal of Diabetes 9(12) July 2017 DOI: 10.1111/1753-0407.12587
27. Lana V, Shahnawaz A, Farzana F & Fahmida D Self-care practices and barriers to compliance among patients with diabetes in a community in rural Bangladesh Int J Diabetes Dev Ctries DOI 10.1007/s13410-015-0460-7
28. Liesbeth VH, Charles RVT and others. Dietary Restriction and Exercise for Diabetic Patients with Chronic Kidney Disease: A Systematic Review. PLoS One. 2014; 9(11): e113667. doi: [10.1371/journal.pone.0113667] PMID: 25423489
29. George C, Goedecke JH and others. The Role of Body Fat and Fat Distribution in Hypertension Risk in Urban Black South African Women. PLoS One. 2016; 11(5): e0154894. doi: [10.1371/journal.pone.0154894] PMID: 27171011
30. Ainslie MH, Amit XG. Blood pressure targets in chronic kidney disease: Does proteinuria dictate how low we go? CMAJ. 2013 Aug 6; 185(11): 941–942. doi: [10.1503/cmaj.130168] PMID: 23798457
31. Eric J, David AC. Management of Hypertension in CKD: Beyond the Guidelines. Adv Chronic Kidney Dis. 2015 Mar; 22(2): 116–122. doi: [10.1053/j.ackd.2014.12.001] PMID: 25704348
32. Susanne B, Nosratola DV, Keith CN. What should be the blood pressure target for patients with chronic kidney disease? Curr Opin Cardiol. 2013 Jul; 28(4): 10.1097/HCO.0b013e32836208c2. doi: [10.1097/HCO.0b013e32836208c2] PMID: 23736818
33. Faqah A, Jafar TH. Control of Blood Pressure in Chronic Kidney Disease: How Low to Go? Nephron Clin Pract 2011;119:c324–c332 https://doi.org/10.1159/000331066
34. Vikram P, Adam WC, George B. Hypertension Management in Diabetic Kidney Disease Diabetes Spectr. 2015 Aug; 28(3): 175–180. doi: [10.2337/diaspect.28.3.175] PMID: 26300610
35. Daniel EW, Mark JS. Managing Dyslipidemia in Chronic Kidney Disease J Gen Intern Med. 2004 Oct; 19(10): 1045–1052. doi: [10.1111/j.1525-1497.2004.40049.x] PMID: 15482558
36. Kalaitzidis RG, Elisaf MS. The Role of Statins in Chronic Kidney Disease. Am J Nephrol 2011;34:195–202 https://doi.org/10.1159/000330355
37. Sanjay K, Bharti K, Navneet A. Combination therapy in hypertension: An update. Diabetol Metab Syndr. 2010; 2: 44. doi: [10.1186/1758-5996-2-44] PMID: 20576135
38. Rabi Y and Kirk NC. Int J Nephrol Renovasc Dis. 2015; 8: 29–40. doi: [10.2147/IJNRD.S37893] PMID: 25926752
39. Luz LM and Adriana PG. Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences J Clin Med. 2015 Nov; 4(11): 1908–1937. doi: [10.3390/jcm4111908] PMID: 26569322
40. Susan S. Management of Hypertension in Diabetic Patients With Chronic Kidney Disease Diabetes Spectrum 2008 Jan; 21(1): 30-36. https://doi.org/10.2337/diaspect.21.1.30
41. Care Process Model MANAGEMENT OF High
42. Blood Pressure 2018 Update, March 2018
43. Daniel EW, Mark JS. Managing Dyslipidemia in Chronic Kidney Disease J Gen Intern Med. 2004 Oct; 19(10): 1045–1052. doi: [10.1111/j.1525-1497.2004.40049.x] PMID: 15482558
44. Daiji K, Keiichiro M and others. SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy Int J Mol Sci. 2017 May; 18(5): 1083. doi: [10.3390/ijms18051083] PMID: 28524098
45. Sun MK, Kyeong MK and others. Erythropoiesis-stimulating Agents and Anemia in Patients with Non-dialytic Chronic Kidney Disease J Korean Med Sci. 2016 Jan; 31(1): 55–60. doi: [10.3346/jkms.2016.31.1.55] PMID: 26770038

Terms of Use/Privacy Policy/ Disclaimer/ Other Policies:
You agree that by using our site, you have read, understood, and agreed to be bound by all of our terms of use/privacy policy/ disclaimer/ other policies (click here for details).

This work and its PDF file(s) are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.